Skip to main content
Top
Published in: Diabetologia 4/2009

01-04-2009 | Article

Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score—the CoLaus Study

Authors: X. Lin, K. Song, N. Lim, X. Yuan, T. Johnson, A. Abderrahmani, P. Vollenweider, H. Stirnadel, S. S. Sundseth, E. Lai, D. K. Burns, L. T. Middleton, A. D. Roses, P. M. Matthews, G. Waeber, L. Cardon, D. M. Waterworth, V. Mooser

Published in: Diabetologia | Issue 4/2009

Login to get access

Abstract

Aims/hypothesis

Several susceptibility genes for type 2 diabetes have been discovered recently. Individually, these genes increase the disease risk only minimally. The goals of the present study were to determine, at the population level, the risk of diabetes in individuals who carry risk alleles within several susceptibility genes for the disease and the added value of this genetic information over the clinical predictors.

Methods

We constructed an additive genetic score using the most replicated single-nucleotide polymorphisms (SNPs) within 15 type 2 diabetes-susceptibility genes, weighting each SNP with its reported effect. We tested this score in the extensively phenotyped population-based cross-sectional CoLaus Study in Lausanne, Switzerland (n = 5,360), involving 356 diabetic individuals.

Results

The clinical predictors of prevalent diabetes were age, BMI, family history of diabetes, WHR, and triacylglycerol/HDL-cholesterol ratio. After adjustment for these variables, the risk of diabetes was 2.7 (95% CI 1.8–4.0, p = 0.000006) for individuals with a genetic score within the top quintile, compared with the bottom quintile. Adding the genetic score to the clinical covariates improved the area under the receiver operating characteristic curve slightly (from 0.86 to 0.87), yet significantly (p = 0.002). BMI was similar in these two extreme quintiles.

Conclusions/interpretation

In this population, a simple weighted 15 SNP-based genetic score provides additional information over clinical predictors of prevalent diabetes. At this stage, however, the clinical benefit of this genetic information is limited.
Literature
1.
go back to reference Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB Sr (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167:1068–1074PubMedCrossRef Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB Sr (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167:1068–1074PubMedCrossRef
2.
go back to reference Simmons RK, Harding AH, Wareham NJ, Griffin SJ (2007) Do simple questions about diet and physical activity help to identify those at risk of type 2 diabetes? Diabet Med 24:830–835PubMedCrossRef Simmons RK, Harding AH, Wareham NJ, Griffin SJ (2007) Do simple questions about diet and physical activity help to identify those at risk of type 2 diabetes? Diabet Med 24:830–835PubMedCrossRef
3.
go back to reference Katzmarzyk PT, Craig CL, Gauvin L (2007) Adiposity, physical fitness and incident diabetes: the physical activity longitudinal study. Diabetologia 50:538–544PubMedCrossRef Katzmarzyk PT, Craig CL, Gauvin L (2007) Adiposity, physical fitness and incident diabetes: the physical activity longitudinal study. Diabetologia 50:538–544PubMedCrossRef
4.
go back to reference Macchia A, Levantesi G, Borrelli G et al (2006) A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico (GISSI)—Prevenzione scoring. Am Heart J 151:754.e7–754.e17CrossRef Macchia A, Levantesi G, Borrelli G et al (2006) A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto miocardico (GISSI)—Prevenzione scoring. Am Heart J 151:754.e7–754.e17CrossRef
5.
go back to reference Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ (2008) A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract 25:191–196PubMedCrossRef Rahman M, Simmons RK, Harding AH, Wareham NJ, Griffin SJ (2008) A simple risk score identifies individuals at high risk of developing type 2 diabetes: a prospective cohort study. Fam Pract 25:191–196PubMedCrossRef
6.
go back to reference Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341–1345PubMedCrossRef Scott LJ, Mohlke KL, Bonnycastle LL et al (2007) A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316:1341–1345PubMedCrossRef
7.
go back to reference Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341PubMedCrossRef Zeggini E, Weedon MN, Lindgren CM et al (2007) Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316:1336–1341PubMedCrossRef
8.
go back to reference Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645PubMedCrossRef Zeggini E, Scott LJ, Saxena R et al (2008) Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet 40:638–645PubMedCrossRef
9.
go back to reference Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657–662PubMedCrossRef Frayling TM (2007) Genome-wide association studies provide new insights into type 2 diabetes aetiology. Nat Rev Genet 8:657–662PubMedCrossRef
10.
go back to reference Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336PubMedCrossRef Saxena R, Voight BF, Lyssenko V et al (2007) Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316:1331–1336PubMedCrossRef
11.
go back to reference Bottinger EP (2007) Foundations, promises and uncertainties of personalized medicine. Mt Sinai J Med 74:15–21PubMedCrossRef Bottinger EP (2007) Foundations, promises and uncertainties of personalized medicine. Mt Sinai J Med 74:15–21PubMedCrossRef
12.
go back to reference Scheuner MT, Sieverding P, Shekelle PG (2008) Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA 299:1320–1334PubMedCrossRef Scheuner MT, Sieverding P, Shekelle PG (2008) Delivery of genomic medicine for common chronic adult diseases: a systematic review. JAMA 299:1320–1334PubMedCrossRef
13.
go back to reference Couzin J (2008) Genetic risk. With new disease genes, a bounty of questions. Science 319:1754–1755PubMedCrossRef Couzin J (2008) Genetic risk. With new disease genes, a bounty of questions. Science 319:1754–1755PubMedCrossRef
14.
go back to reference Lyssenko V, Almgren P, Anevski D et al (2005) Genetic prediction of future type 2 diabetes. PLoS Med 2:e345PubMedCrossRef Lyssenko V, Almgren P, Anevski D et al (2005) Genetic prediction of future type 2 diabetes. PLoS Med 2:e345PubMedCrossRef
15.
go back to reference Weedon MN, McCarthy MI, Hitman G et al (2006) Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 3:e374PubMedCrossRef Weedon MN, McCarthy MI, Hitman G et al (2006) Combining information from common type 2 diabetes risk polymorphisms improves disease prediction. PLoS Med 3:e374PubMedCrossRef
16.
go back to reference Vaxillaire M, Veslot J, Dina C et al (2008) Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 57:244–254PubMedCrossRef Vaxillaire M, Veslot J, Dina C et al (2008) Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 57:244–254PubMedCrossRef
17.
go back to reference Lu Q, Elston RC (2008) Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes. Am J Hum Genet 82:641–651PubMedCrossRef Lu Q, Elston RC (2008) Using the optimal receiver operating characteristic curve to design a predictive genetic test, exemplified with type 2 diabetes. Am J Hum Genet 82:641–651PubMedCrossRef
18.
go back to reference Lango H, Palmer CN, Morris AD et al (2008) Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57:3129–3135PubMedCrossRef Lango H, Palmer CN, Morris AD et al (2008) Assessing the combined impact of 18 common genetic variants of modest effect sizes on type 2 diabetes risk. Diabetes 57:3129–3135PubMedCrossRef
19.
go back to reference Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359:2208–2219PubMedCrossRef Meigs JB, Shrader P, Sullivan LM et al (2008) Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 359:2208–2219PubMedCrossRef
20.
go back to reference Lyssenko V, Jonsson A, Almgren P et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359:2220–2232PubMedCrossRef Lyssenko V, Jonsson A, Almgren P et al (2008) Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359:2220–2232PubMedCrossRef
21.
go back to reference Firmann M, Mayor V, Marques VP et al (2008) The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8:6PubMedCrossRef Firmann M, Mayor V, Marques VP et al (2008) The CoLaus study: a population-based study to investigate the epidemiology and genetic determinants of cardiovascular risk factors and metabolic syndrome. BMC Cardiovasc Disord 8:6PubMedCrossRef
22.
go back to reference Sandhu MS, Waterworth DM, Debenham SL et al (2008) LDL-cholesterol concentrations: a genome-wide association study. Lancet 371:483–491PubMedCrossRef Sandhu MS, Waterworth DM, Debenham SL et al (2008) LDL-cholesterol concentrations: a genome-wide association study. Lancet 371:483–491PubMedCrossRef
23.
go back to reference Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172PubMedCrossRef Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27:157–172PubMedCrossRef
24.
go back to reference D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286:180–187PubMedCrossRef D’Agostino RB Sr, Grundy S, Sullivan LM, Wilson P (2001) Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 286:180–187PubMedCrossRef
25.
go back to reference Delong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845PubMedCrossRef Delong ER, DeLong DM, Clarke-Pearson DL (1988) Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837–845PubMedCrossRef
26.
go back to reference Todd JA, Walker NM, Cooper JD et al (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857–864PubMedCrossRef Todd JA, Walker NM, Cooper JD et al (2007) Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 39:857–864PubMedCrossRef
Metadata
Title
Risk prediction of prevalent diabetes in a Swiss population using a weighted genetic score—the CoLaus Study
Authors
X. Lin
K. Song
N. Lim
X. Yuan
T. Johnson
A. Abderrahmani
P. Vollenweider
H. Stirnadel
S. S. Sundseth
E. Lai
D. K. Burns
L. T. Middleton
A. D. Roses
P. M. Matthews
G. Waeber
L. Cardon
D. M. Waterworth
V. Mooser
Publication date
01-04-2009
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2009
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-008-1254-y

Other articles of this Issue 4/2009

Diabetologia 4/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine